Immunovia AB (publ) (LON: 0G8X)
London flag London · Delayed Price · Currency is GBP · Price in SEK
0.489
-0.023 (-4.49%)
Jan 21, 2025, 8:07 AM BST

Immunovia AB Market Cap

Immunovia AB has a market cap or net worth of 5.85 million as of January 23, 2025. Its market cap has decreased by -23.87% in one year.

Market Cap
5.85M
Enterprise Value
1.96M
Revenue
46.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49

Market Cap Chart

Since December 1, 2015, Immunovia AB's market cap has decreased from 32.41M to 5.85M, a decrease of -81.96%. That is a compound annual growth rate of -17.07%.

History

DateMarket Cap% Change
Jan 22, 20255.85M-12.77%
Dec 30, 20246.70M7.32%
Dec 29, 20236.25M-86.82%
Dec 30, 202247.39M-65.91%
Dec 30, 2021139.03M-42.58%
Dec 30, 2020242.14M-16.01%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 171.37B
GSK plc 55.43B
Haleon 33.25B
Smith & Nephew 9.04B
ConvaTec Group 4.92B
Hikma Pharmaceuticals 4.68B
HUTCHMED (China) 1.94B
Oxford Nanopore Technologies 1.48B
Market Cap Rankings